Skip to main content
Michael Kastan, MD, Pediatric Hematology & Oncology, Durham, NC

MichaelBKastanMD

Pediatric Hematology & Oncology Durham, NC

Professor of Pharmacology and Cancer Biology, Duke University School of Medicine and Executive Director, Duke Cancer Institute

Dr. Kastan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kastan's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1986 - 1989
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1984 - 1986
  • Washington University in St. Louis
    Washington University in St. LouisPh.D., 1977 - 1984
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1984
  • University of North Carolina System
    University of North Carolina SystemB.S., Chemistry, with Highest Honors, 1973 - 1977

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2011 - 2024
  • TN State Medical License
    TN State Medical License 1998 - 2013
  • American Board of PediatricsSubspeciatly Board of Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Elected Fellow of the AACR Academy American Association for Cancer Research, 2017
  • Elected National Academy of Sciences National Academy of Sciences, 2016
  • Elected Fellow American Association for the Advancement of Science, 2013
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy  
    Goldstein M, Kastan MB, Annual Review of Medicine, 1/1/2015
  • Repair versus checkpoint functions of Brca1 are differentially regulated by site of chromatin binding  
    Goldstein M, Kastan MB, Cancer Res, 1/1/2015
  • ATM Functions at the Peroxisome to Induce Pexophagy in Response to ROS  
    Zhang J,, Tripathi DN, Jing, J, Alexander A, Kim J, Powell RT, Dere R, Tait-Mulder J, Lee J-H, Paull TT, Pandita RK, Charaka VK, Pandita TK, Kastan MB, Walker CL, Nature Cell Biology, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Genome Dynamics in Neuroscience 
    Hong Kong - 1/1/2017
  • Ataxia Telangiectasia Workshop 
    Milan, Italy - 1/1/2017
  • Mitochondria and Cancer 
    1/1/2015
  • Join now to see all

Other

  • Ataxia-telangiectasia: defective in a p53-dependent signal transduction pathway. 
    Kastan MB, Ataxia-Telangiectasia Workshop V
    1/1/1993
  • DNA Methylation in Human Fibroblasts Following DNA Damage and Repair 
    Kastan MB, Ph.D. Thesis
    Washington University School of Medicine, St. Louis, MO - 1/1/1984

Press Mentions

  • Developing New Tools to Fight Cancer
    Developing New Tools to Fight CancerOctober 17th, 2022
  • White Glove Service for Brain and Spine Metastasis Patients
    White Glove Service for Brain and Spine Metastasis PatientsAugust 25th, 2022
  • "We're Going to Get There": 50 Years After Start of 'War on Cancer,' Hopes Persist for More Progress
    "We're Going to Get There": 50 Years After Start of 'War on Cancer,' Hopes Persist for More ProgressDecember 24th, 2021
  • Join now to see all

Grant Support

  • Chromatin Modulation Associated With DNA Breakage And Repair In Human CellsNational Cancer Institute2011–2012
  • ATM, Reactive Oxygen, And Cellular Responses To HypoxiaNational Cancer Institute2011–2012
  • Cellular Stress Response Signaling PathwaysNational Institute Of Environmental Health Sciences2011
  • Duke Comp Cancer Inst. Core Support GrantNational Cancer Institute2011
  • Chromatin Modulation Associated With DNA Breakage And Repair In Human CellsNational Cancer Institute2011
  • ATM, Reactive Oxygen, And Cellular Responses To HypoxiaNational Cancer Institute2011
  • Senior LeadershipNational Cancer Institute2008–2011
  • Program LeadersNational Cancer Institute2008–2011
  • Planning And EvaluationNational Cancer Institute2008–2011
  • DevelopmentNational Cancer Institute2008–2011
  • CarryoverNational Cancer Institute2008–2011
  • Cancer Center Support Grant (CCSG)National Cancer Institute2008–2011
  • Cellular Stress Response Signaling PathwaysNational Institute Of Environmental Health Sciences2002–2011
  • Role Of SMC1 Phosphorylation In Radiation ResponsesNational Cancer Institute2002–2010
  • Functional Characterization Of The ATM Gene ProductNational Cancer Institute2000–2009
  • St.Jude Children'S Cancer Center Support Grant (CCSG)National Cancer Institute2005–2007
  • Molecular Mechanisms Of Mammalian Checkpoint PathwaysNational Cancer Institute2001–2004
  • Workshop On Molecular Biology In Clinical OncologyNational Cancer Institute2000–2004
  • Signaling Pathways /Stress Responses In Mammalian CellsNational Cancer Institute2002
  • P53 And The Cellular Response To DNA DamageNational Institute Of Environmental Health Sciences1998–2001
  • Redox And Growth Factor Modulation Of RadiosensitivityNational Cancer Institute1998–2000
  • Molecular Biology In Clinical OncologyNational Cancer Institute1998–1999
  • ATM Gene And Cellular Responses To IrradiationNational Cancer Institute1998–1999
  • Redox And Growth Factor Modulation Of RadiosensitivityNational Cancer Institute1998
  • ATM Gene And Cellular Responses To IrradiationNational Cancer Institute1996–1998
  • P53 And The Cellular Response To DNA DamageNational Institute Of Environmental Health Sciences1994–1998
  • P53, MYC, Genetic Instability And Cell Survival After IRNational Cancer Institute1994–1997
  • Role Of P53 In The Cellular Response To DNA DamageNational Institute Of Environmental Health Sciences1992–1993